tbuckley/cabot-search huggingface dataset:
Safety and Tolerability of Magrolimab Combinations in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Safety Run-in Results from a Phase 2 Study
Authors: Barry Paul, Jirí Minarík, Francesca Cottini, Cristina Gasparetto, Jack Khouri, Mitul Gandhi, Jens Hillengass, Moshe Levy, Michaela Liedtke, Sudhir Manda, Irwindeep Sandhu, Douglas Sborov, Ivan Spicka, Saad Z Usmani, Lin Gu, Michelle Robeson, Michael Murphy, Camille Renard, Christine Chen, Luděk Pour
Journal: Blood (2023)
Once-Weekly Efanesoctocog Alfa Prophylaxis Provided High Sustained Factor VIII Activity Levels, Independent of Blood Group, in Children &amp;lt;12 Years of Age with Severe Hemophilia A
Authors: Flora Peyvandi, Cristina Tarango, Mindy Simpson, Manuela Albisetti, Maria Teresa Álvarez-Roman, Anthony KC Chan, Julie Curtin, Linda Bystrická, Elena Santagostino, Ekaterina Gresko, Sriya Gunawardena, Chandravathi Vage, Nancy Wong
Journal: Blood (2023)
Single Cell Profiling Unravels Plasma Cell Gene Expression Signatures Predictive of Response to Daratumumab Based Therapy, and Prognosis in Multiple Myeloma
Authors: Jonathan Scolnick, Stacy Xu, Cinnie Soekojo, Fangfang Song, Melissa Ooi, Chandramouli Nagarajan, Wee-Joo Chng, Sanjay De Mel
Journal: Blood (2023)
Dual Targeting of Slamf-7 and CD38 in Mulitple Myeloma (MM): A Phase II Study of Isatuximab, Elotuzumab, Pomalidomide and Dexamethasone (Isa-EloPD) in Relapsed and/or Refractory MM (RRMM)
Authors: Binod Dhakal, Meera Mohan, Ravi Narra, Katie Palen, Aniko Szabo, Tyce Kearl, Gayathri Ravi, Susan Bal, Bryon D. Johnson, Marcelo Pasquini, Anita D'Souza, Parameswaran N. Hari, Luciano Costa
Journal: Blood (2023)
Ibrutinib in Combination with Revlimid/Dexamethasone (Rd) in Relapsed/Refractory Multiple Myeloma (AFT-15)
Authors: Yvonne Efebera, Vera Jean Suman, Shira N. Dinner, Ashley E Rosko, John T Mckay, Peter Barth, Patrick Hagen, Saad Z Usmani, Paul G. Richardson, Jacob P. Laubach
Journal: Blood (2023)
Trial in Progress: A Phase 2 Study of Linvoseltamab for the Treatment of High-Risk Smoldering Multiple Myeloma (LINKER-SMM1)
Authors: Paula Rodriguez Otero, Maria-Victoria Mateos, Oluwaseun Aina, Arijit Sinha, Andrew J Steele, Anasuya Hazra, Karen Rodriguez Lorenc, Glenn S. Kroog, Shawn M Sarkaria, Jesus San Miguel
Journal: Blood (2023)
Longitudinal Screening of Mutant Hematopoietic Progenitor Cells (HPC) in Multiple Myeloma (MM) and Its Association with Secondary Primary Malignancies (SPM)
Authors: Cristina Perez, Maria Jose Larrayoz, Iria Vazquez, Irache Erdozain, Noemi Puig, María T Cedena, Catarina Maia, Amagoia Mañu, Natalia Gordillo, Oihane Churruca, Diego Alignani, Sarai Sarvide, Albert Oriol Rocafiguera, Laura Rosiñol, Rafael Ríos, Marta Sonia Gonzalez Perez, Ana Pilar Gonzalez-Rodriguez, Felipe De Arriba, Jose Maria Moraleda, Jesus Martin Sanchez, Luis Palomera, Valentin Cabanas Perianes, Maria Jose Calasanz, Joaquin Martinez-Lopez, Maria Victoria Mateos, Joan Bladé, Juan Jose Lahuerta Palacios, Jesus San-Miguel, Bruno Paiva
Journal: Blood (2023)
Whole Exome Sequencing Analysis of Diffuse Large B-Cell Lymphoma That Progressed to Central Nervous System
Authors: Tomotaka Suzuki, Rui Yokomori, Takaomi Sanda, Hiroki Yano, Takaki Kikuchi, Takashi Kanamori, Atsushi Inagaki, Takashi Yoshida, Satoshi Kayukawa, Yoshiko Oshima, Hirokazu Sasaki, Shiori Kinoshita, Tomoko Narita, Ayako Masaki, Masaki Ri, Shigeru Kusumoto, Hirokazu Komatsu, Hiroshi Inagaki, Shinsuke Iida
Journal: Blood (2023)
Plasma Transforming Growth Factor-β1 (TGF-β1) Levels Increase with Age and Aortic Stenosis Progression and Low-Dose Galunisertib Attenuates Disease Progression in Mice
Authors: Kumar Subramani, Rohan Varshney, Sandeep Subramanian, Jeffrey Bander, Denys Babii, Jasimuddin Ahamed
Journal: Blood (2023)
Efficacy of Brentuximab Vedotin Maintenance Therapy Following Autologous Stem Cell Transplantation in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma with and without Pre-Transplant Exposure to Novel Agents
Authors: Ayo S Falade, Robert A. Redd, Harsh Shah, Kelsey Baron, Siddharth Iyengar, Sanjal H. Desai, Stephen M Ansell, Ivana Micallef, Adrienne Nedved, Nivetha Ganesan, Tiffany Chang, Gunjan L. Shah, Robert Stuver, Alison Moskowitz, Matthew Genyeh Mei, Tamer Othman, Shin Yeu Ong, Alex F. Herrera, Philippe Armand, Reid W. Merryman
Journal: Blood (2023)
A First-in-Human Phase I Study of AT101, a Novel Anti-CD19 Chimeric Antigen Receptor T Cell Product Targeting a Membrane-Proximal Domain of CD19 in Adults with Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
Authors: Yunlin Zhang, Ruchi P. Patel, Ki Hyun Kim, Hyungwoo Cho, Jae-Cheol Cho, Seong Hyun Jeong, Sung Yong Oh, Yoon Seok Choi, Sung-Hyun Kim, Ji Hyun Lee, Mathew G. Angelos, Puneeth Guruprasad, Ivan J Cohen, Ositadimma Ugwuanyi, Yong Gu Lee, Raymone Pajarillo, Jong Hyun Cho, Alberto Carturan, Luca Paruzzo, Guido Ghilardi, Soohwan Kim, Sung Min Kim, Hyun Jong Lee, Ji Ho Park, Lei Guang Cui, Tae Bum Lee, Insik Hwang, Youngha Lee, Yong-Jun Lee, Patrizia Porazzi, Dongfang Liu, Yoon Lee, Jong Hoon Kim, Jong Seo Lee, Dok Hyun Yoon, Junho Chung, Marco Ruella
Journal: Blood (2023)
A Multi-Modal Analysis of Acquired Resistance to Acalabrutinib and Pirtobrutinib Provides Potential Strategies to Augment Treatment Outcome with BTKi Drugs
Authors: Xiaoyun Wu, Shariful Islam, Derek B Oien, Collin Tokheim, Alex Beacom, Neeraj Aryal, Michelle Hsueh, Muskan Floren, Douglas Ross-Thriepland, Daniel Barrell, Ultan McDermott, Veerendra Munugalavadla, Daniel Auclair, Simon Rule, Arthur Shaffer, Jude Fitzgibbon, Lisa Drew
Journal: Blood (2023)
Outcome of Newly Diagnosed Children and Adolescents with Localized Lymphoblastic Lymphoma Treated on JPLSG-LLB-NHL03 Trial: A Report from the Japan Children's Cancer Group
Authors: Masahiro Sekimizu, Tomoyuki Watanabe, Tetsuya Mori, Ryoji Kobayashi, Atsuko Nakazawa, Akiko M Saito, Tetsuya Takimoto, Masahito Tsurusawa, Keizo Horibe, Yasuhiro Okamoto, Shosuke Sunami
Journal: Blood (2023)
Homoharringtonine Enhances the Anti-Leukemia Effect of Venetoclax in Acute Myeloid Leukemia with t(8;21)(q22;q22) Via Regulation of c-Myc/Bim Axis
Authors: Guopan Yu, Zhao Yin, Zurong Yao, Xiaqi Nie, Hua Jin, Yu Zhang, Dan Xu, Xuejie Jiang, Baohong Ping
Journal: Blood (2023)
Bleomycin Affects Lung Function for at Least 5 Years after Treatment for Hodgkin Lymphoma - Data from the International, Randomised Phase 3 Rathl Trial
Authors: Elizabeth H Phillips, Amy A Kirkwood, Christina Hague, Jorgen Vestbo, Massimo Federico, Francesco D'Amore, Alexander Fossa, Judith Trotman, Leanne Berkahn, Daniel L. Molin, Stefano Luminari, Sally F Barrington, Peter Johnson, John Radford
Journal: Blood (2023)
Comparison between Dasatinib-Blinatumomab Vs Ponatinib-Blinatumomab Chemo-Free Strategy for Newly Diagnosed Ph+ Acute Lymphoblastic Leukemia Patients. Preliminary Results of the Gimema ALLL2820 Trial
Authors: Sabina Chiaretti, Matteo Leoncin, Loredana Elia, Alfonso Piciocchi, Mabel Matarazzo, Mariangela Di Trani, Simona Sica, Mario Luppi, Valentina Mancini, Erika Borlenghi, Silvia Imbergamo, Carmine Selleri, Giuseppe Visani, Bruno Martino, Daniele Vallisa, Calogero Vetro, Stefano Soddu, Monica Messina, Paola Fazi, Alessandro Rambaldi, Robin Foà
Journal: Blood (2023)
CRISPR/Cas9 Screen Identifies CPX-351 and 7+3 Regimens Response Modulators with Distinct Sensitive and Resistant Profiles
Authors: Nam Nguyen, Phani Krishna Parcha, Abderrahmane Tagmount, Bailey Gregory, Xueyuan Cao, Stanley Pounds, Christopher Vulpe, Jatinder K. Lamba
Journal: Blood (2023)
<i>In</i>-Class Transition ( <i>i</i>CT) from Parenteral Bortezomib (V) to Oral Ixazomib Therapy in Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts) in the Community-Based US MM-6 Study: Subanalysis of Randomized Controlled Trial (RCT)-Ineligible and RCT-Eligible Pts
Authors: Saulius K. Girnius, Joshua Richter, Kimberly Bogard, Habte A. Yimer, Sudhir Manda, Roger M. Lyons, Stephen J. Noga, Robert M. Rifkin
Journal: Blood (2023)
Safety and Efficacy of Relmacabtagene Autoleucel (relma-cel) in Adults with Relapsed/Refractory Mantle Cell Lymphoma (r/r MCL): Updated Results from a Phase II Open-Label Study in China
Authors: Yuqin Song, Keshu Zhou, Lanfang Li, Aibin Liang, Yun Qin, Zhen Xia, Yongen Gu, Zisong Zhou, Alex Tian, Jun Zhu
Journal: Blood (2023)
Single Cell Multi Omics and Spatial Analysis Reveals Plasmablast Signature Malignant Cells As a Key of Intratumor Heterogeneity in Primary Central Nervous System Lymphoma
Authors: Hiroki Kobayashi, Ryota Chijimatsu, Ryo Mizuta, Kentaro Fujii, Yoshihiro Otani, Joji Ishida, Yusuke Naoi, Hiroyuki Murakami, Hideki Ujiie, Kazuhiro Ikeuchi, Tomohiro Urata, Katsuma Tani, Akira Yamamoto, Keisuke Seike, Hideaki Fujiwara, Noboru Asada, Hisakazu Nishimori, Keiko Fujii, Nobuharu Fujii, Ken-ichi Matsuoka, Yasuharu Sato, Tadashi Yoshino, Yoshinobu Maeda, Daisuke Ennishi
Journal: Blood (2023)
Revised Definition of Free Light Chains in Serum and Light Chain Monoclonal Gammopathy of Undetermined Significance: Results of the Istopmm Study
Authors: Thorir Einarsson Long, Sæmundur Rögnvaldsson, Sigrun Thorsteinsdottir, Ingigerdur Sverrisdottir, Elias Eythorsson, Olafur Indridason, Runolfur Palsson, Thor Aspelund, Brynjar Vidarsson, Pall T. Onundarson, Bjarni Agnarsson, Margret Sigurdardottir, Ingunn Thorsteinsdottir, Isleifur Olafsson, Asdis Rosa Thordardottir, Asbjorn Jonsson, Gauti Gislason, Andri Olafsson, Malin Hultcrantz, Brian GM Durie, Stephen J. Harding, Thorvardur Jon Love, Ola Landgren, Sigurdur Y. Kristinsson
Journal: Blood (2023)
Safety and Efficacy of Lisaftoclax (APG-2575), a Novel BCL-2 Inhibitor (BCL-2i), in Relapsed or Refractory (R/R) or Treatment-Naïve (TN) Patients (Pts) with Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), or Other Myeloid Neoplasms
Authors: Huafeng Wang, Xudong Wei, Qian Jiang, Wenjun He, Qiubai Li, Yang Liang, Jianyu Weng, Suning Chen, Hongbing Ma, Chukang Chang, Yajing Xu, Qun He, Zi Chen, Lihui Liu, Lichuang Men, Danhua Cong, Zhang Zhang, Dajun Yang, Yifan Zhai, Jie Jin
Journal: Blood (2023)
High Dimensional Detection of Non-Malignant B-Cells and Its Clinical Implications in Patients with Chronic Lymphocytic Leukaemia (CLL) Undergoing Frontline Therapy
Authors: Yeong Jer Lim, Andrew Duckworth, Kim Clarke, Melanie Oates, Matthew Gornall, Nagesh Kalakonda, Joseph Slupsky, Andrew Pettitt
Journal: Blood (2023)
A Phase 2 Study of Acalabrutinib, Umbralisib, and Ublituximab (AU2) in Treatment-Naïve and Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Authors: Inhye E Ahn, Yinglu Zhou, Svitlana Tyekucheva, Hannah Cormier, Stacey M Fernandes, Josie Montegaard, Marykate Kilcommons, Jennifer L Crombie, Reid W. Merryman, Erin M Parry, Philippe Armand, David C Fisher, Caron A Jacobson, Matthew S Davids, Jennifer R. Brown
Journal: Blood (2023)
Updated Results from Phase 1 Study of Targeted Radiotherapy with Lintuzumab-Ac225 in Combination with Venetoclax in Relapsed/Refractory AML
Authors: Gail J. Roboz, Laura E. Finn, Johnnie J. Orozco, Mohamed Hegazi, Avinash Desai, Mary Chen, Gary J. Schiller
Journal: Blood (2023)
Socioeconomic Determinants and the Biology and Outcomes of Acute Lymphoblastic Leukemia in Adults
Authors: Hannah Johnston, Hamed Youshanlouei, Clinton Osei, Anand Ashwin Patel, Adam S Duvall, Peng Wang, Pankhuri Wanjari, Jeremy Segal, Girish Venkataraman, Sandeep Gurbuxani, Angela Lager, Carrie Fitzpatrick, Michael J Thirman, Christopher Daugherty, Mariam T. Nawas, Hongtao Liu, Michael Drazer, Olatoyosi Odenike, Richard Larson, Wendy Stock, Caner Saygin
Journal: Blood (2023)
The Impact of KIR-HLA Interplay in T-LGL Leukemia
Authors: Aashray Mandala, Carlos Bravo-Perez, Nakisha D Williams, Christopher Haddad, Luca Guarnera, Simona Pagliuca, Serhan Unlu, Yasuo Kubota, Naomi Kawashima, Carmelo Gurnari, Valeria Visconte, Arda Durmaz, Jaroslaw P. Maciejewski
Journal: Blood (2023)
Label-Free Cell Detection of Acute Leukemia Using High-Content Morphological Profiling in Flow
Authors: Yoko Kawamura, Kayoko Nakanishi, Yuri Murata, Kazuki Teranishi, Ryusuke Miyazaki, Keisuke Toda, Toru Imai, Yasuhiro Kajiwara, Keiji Nakagawa, Hidemasa Matsuo, Souichi Adachi, Sadao Ota, Hidefumi Hiramatsu
Journal: Blood (2023)
Acquired Venetoclax Resistance in an <i>In Vivo</i> Model of B-Cell Precursor Acute Lymphoblastic Leukemia Is Characterized By Altered Functions of Apoptosis Regulators
Authors: Stefanie Enzenmüller, Alexandra Niedermayer, Felix Seyfried, Alexander Groß, Klaus-Michael Debatin, Lüder Hinrich Meyer
Journal: Blood (2023)
Effect of Immunopeptidome Gap Caused By Recipient-Donor HLA Mismatch in Umbilical Cord Blood Transplantation and HLA-Haploidentical Hematopoietic Stem Cell Transplantation
Authors: Kyoko Fuse, Tatuya Suwabe, Takayuki Katagiri, Yasuhiko Shibasaki, Hirohito Sone, Masayoshi Masuko
Journal: Blood (2023)
Real-Life Experience with Lenalidomide Plus Anti-CD20 Antibodies for the Treatment of Patients (pts) with Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (iNHL)
Authors: Giulio Cassanello, Alfredo Rivas-Delgado, Alejandro Luna De Abia, Magdalena Corona, Efrat Luttwak, Michelle Okwali, Irem Isgor, Pallavi Galera, Alexander P. Boardman, Philip Caron, Kevin A. David, Zachary D. Epstein-Peterson, Paola Ghione, Paul A. Hamlin, Jennifer Kimberly Lue, Steven M. Horwitz, Andrew M. Intlekofer, William Johnson, Anita Kumar, Alison Moskowitz, Ariela Noy, Colette Owens, Maria Lia Palomba, Robert Stuver, Pallawi Torka, Santosha A Vardhana, Andrew D. Zelenetz, Gilles Salles, Lorenzo Falchi
Journal: Blood (2023)
Reduced-Dose Chemotherapy Followed By Blinatumomab As Induction Therapy in Treatment of Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia - Interim Results from a Multicenter, Single-Arm, Phase 2 Study
Authors: Jing Lu, Ying Wang, Huiying Qiu, Xin Zhou, Xuzhang Lu, Miao Miao, Bin Gu, Xiaohui Hu, Depei Wu, Suning Chen
Journal: Blood (2023)
Outcomes of B-Cell Acute Lymphoblastic Leukemia Patients Who Relapse after Blinatumomab Salvage Therapy - a Tertiary Centre Experience
Authors: Jing Yuan Tan, Nurul Aidah Abdul Halim, Chieh Hwee Ang, Tertius Transloan Tuy, Hein Than, Zhentang Lao, Francesca Lorraine Wei Inng Lim, Yeh Ching Linn, Aloysius Yew Leng Ho, William Ying Khee Hwang, Gee Chuan Wong
Journal: Blood (2023)
Evaluation of the Impact of a Naturally Occurring Beta Hemoglobin Variant, Hb G-Makassar, on Mature Red Blood Cell Function and Pathology in a Sickle Cell Disease Mouse Model
Authors: Zachary Kostamo, Jawa Darazim, Britney Hernandez, Alex Pendergast, Jordan Zgodny, Erica N Evans, Yankai Zhang, Ashwin P Patel, Celeste K. Kanne, Elizabeth Budak, Rebecca Jenkins, Daniel Haupt, Valerie Winton, Bo Yan, Adam Hartigan, Haihua Chu, Giuseppe Ciaramella, Vivien A. Sheehan
Journal: Blood (2023)
Plm-102, a Next Generation FLT3 Inhibitor, Shows Potent Anti-Leukemic Activity on Resistance to Gilteritinib in FLT3 Mutated Acute Myeloid Leukemia
Authors: Jae-Seon Lee, Min Ji Park, Ningning Sun, Jin-Hee Park, Su-jin Oh, Miran Moon, Myung Jin Kim, Soo Yeon Jang, Yong-Chul Kim
Journal: Blood (2023)
MP0533, a CD3-Engaging Darpin Targeting CD33, CD123, and CD70 in Patients with Relapsed/Refractory AML or MDS/AML: Preliminary Results of a Phase 1/2a Study
Authors: Thomas Pabst, Mojca Jongen-Lavrencic, Steffen Boettcher, Geert A. Huls, David C. de Leeuw, Philippe Legenne, Mariola Dymkowska, Christiane Andrieu, Oliver Schönborn-Kellenberger, Paul G. Baverel, Zita Arany, Elena Fernandez, Anne Goubier, Vladimir Kirkin, Nicolas Leupin, Marion Subklewe
Journal: Blood (2023)
Venetoclax Combined with HMA Versus CAG Based Chemotherapy in Acute Myeloid Leukemia: A Propensity Score Matched Analysis
Authors: Xiaonan Lin, Yuming Zhang, Ying Zhao, Ying Dong, Xiaotao Wang, Pengcheng Huang, Zhenqian Huang, Honghua He, Xiaoli Xu, Yaya Wang, Fang Jiang, Hui Zeng, Rui Huang, Yuhua Li
Journal: Blood (2023)
Functional and Morphological Characterization of RBCs Loaded with Factor IX Conjugated with an Anti-Glycophorin Ā Antibody
Authors: Alina D. Peshkova, Taylor V. Brysgel, Parth Mody, Jia Nong, Zhicheng Wang, Jacob W. Myerson, Rustem I. Litvinov, John W. Weisel, Vladimir R. Muzykantov, Patrick M. Glassman, Oscar A. Marcos-Contreras
Journal: Blood (2023)
Post-Transplant Cyclophosphamide Eliminates Disparity in GvHD-Free, Relapse-Free Survival and Overall Survival between 8/8 Matched and 7/8 Mismatched Unrelated Donor Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies
Authors: Jeffery J. Auletta, Monzr M. Al Malki, Todd DeFor, Brian C. Shaffer, Mahasweta Gooptu, Javier Bolanos-Meade, Ramzi Abboud, Adrienne D. Briggs, Farhad Khimani, Dipenkumar Modi, Richard Newcomb, Elizabeth J. Shpall, Caitrin Bupp, Stephen R. Spellman, Heather E. Stefanski, Antonio M. Jimenez Jimenez, Steven M. Devine
Journal: Blood (2023)
A High-Risk Subgroup Multiple Myeloma Classification Based on the Detection of PR Minor Subclones
Authors: Noemie Leblay, Sungwoo Ahn, Sheri Skerget, Rémi Tilmont, Holly Lee, Mansour Poorebrahim, Daniel Penaherrera, Elie Barakat, David Jung, Nizar J Bahlis, Jonathan Keats, Paola Neri
Journal: Blood (2023)
International, Prospective Study Comparing Nilotinib Versus Imatinib with Early Switch to Nilotinib to Obtain Sustained Treatment-Free Remission in Patients with Chronic Myeloid Leukemia (SUSTRENIM trial): Analysis of the Eligibility to Treatment Discontinuation
Authors: Fabrizio Pane, Fausto Castagnetti, Alfonso Piciocchi, Elisabetta Abruzzese, Renato Bassan, Gianni Binotto, Massimiliano Bonifacio, Giovanni Caocci, Francesco Cavazzini, Giuseppe Cimino, Antonella Gozzini, Monia Lunghi, Roberto Marasca, Bruno Martino, Francesco Muriano, Gianantonio Rosti, Antonella Russo Rossi, Simona Sica, Agostino Tafuri, Daniele Vallisa, Monica Messina, Francesca Paola Paoloni, Paola Fazi, Peter E Westerweel, Jeroen J.W.M. Janssen, Giuseppe Saglio, Massimo Breccia
Journal: Blood (2023)
The Topoisomerase-I Inhibitor Gimatecan Exhibits Potent and Selective Activities Against B-Cell Precursor Acute Lymphoblastic Leukemia with a Favorable Cardiotoxicity Profile
Authors: Han Wang, Kathy Yuen Yee Chan, Po Yi Lee, Chi Zhang, Hung Sing LI, Wai Man Leung, Maxwell Kwok, Po Yee Chung, Wing Hei Ng, John Tak Kit Cheung, Wai Yip Lam, Benjamin Li, Chi Kong Li, Ellen Poon, Kam Tong Leung
Journal: Blood (2023)
Mutations in the RNA Splicing Factors <i>U2AF1</i> and <i>SRSF2</i> are Context-Dependent in Myeloproliferative Neoplasms
Authors: Swarna Bale, Chulwoo J. Kim, Joan How, Mohammed Wazir, Lachelle D. Weeks, Maximilian Stahl, Marlise R. Luskin, Daniel J. DeAngelo, Coleman Lindsley, Annette S. Kim, Ann Mullally, Anna E. Marneth
Journal: Blood (2023)
Preliminary Results of a Phase 2a Clinical Trial to Evaluate Safety, Tolerability and Antiviral Activity of Intravenous Brincidofovir (BCV IV) in Immunocompromised Patients with Adenovirus Infection
Authors: Michael Grimley, Gabriela Maron, Carlos A Gomez, Vinod K. Prasad, Jasmeen Dara, Genovefa A Papanicolaou, Koji Fukushima, Robert F. Wynn, Michael Boeckh
Journal: Blood (2023)
Clinical and Molecular Characterization of Patients with Therapy Related Myeloid Neoplasms (TRMN)
Authors: Oriol Calvete, Julia Mestre, Guillermo Montalban-Bravo, Koji Sasaki, Courtney D. DiNardo, Ana Manzanares, Pamela Acha, Blanca Xicoy, Lurdes Zamora, Isabel Granada, Alvaro Diaz-Gonzalez, Esperanza Such, Laura Palomo, Maria Julia Montoro, Sara García, Leonor Arenillas, David Valcarcel Ferreiras, Andres Jerez, Maria Diez-Campelo, Felipe Prosper, Hui Yang, Carlos E. Bueso-Ramos, Guillermo Garcia-Manero, Francesc Sole, Rashmi Kanagal-Shamanna
Journal: Blood (2023)
Consolidation with Ponatinib Plus Sequential Blinatumomab and Chemotherapy after Low Intensity Dasatinib-Based Induction in Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Outcomes from a Single Institution
Authors: Marc Schwartz, Christine M. McMahon, Maria L Amaya, Matthew Witkowski, Daniel A. Pollyea, Jonathan A Gutman, Mohd Minhajuddin, Clayton Smith, Craig T. Jordan
Journal: Blood (2023)
Efficacy, Safety, and Biomarker Analysis of 5 Mg and 7.5 Mg Doses of Crizanlizumab in Patients with Sickle Cell Disease: Primary Analyses from the Phase III STAND Study
Authors: Miguel R Abboud, Rodolfo D Cançado, Mariane De Montalembert, Wally R Smith, Hala Rimawi, Ersi Voskaridou, Birol Guvenc, Deborah Keefe, Kai Grosch, Michele L Nassin, Jimmy Watson, Justin Yssel, Evgeniya Reshetnyak, Yvonne Dei Adomakoh
Journal: Blood (2023)
The Early Benefits and Psychological Effects of Screening for Monoclonal Gammopathy of Undetermined Significance: Results of the Istopmm Study
Authors: Sæmundur Rögnvaldsson, Sigrun Thorsteinsdottir, Jon Oskarsson, Elias Eythorsson, Gudrun Asta Sigurdardottir, Brynjar Vidarsson, Pall T. Onundarson, Bjarni Agnarsson, Margret Sigurdardottir, Isleifur Olafsson, Ingunn Thorsteinsdottir, Andri Steinthor Bjornsson, Inga Dröfn Wessman, Gauti Gislason, Jon Kristinn Sigurdsson, Andri Olafsson, Ingigerdur Sverrisdottir, Thorir E. Long, Robert Palmason, Signy Vala Sveinsdottir, Fridbjorn Sigurdsson, Asdis Rosa Thordardottir, Asbjorn Jonsson, Runolfur Palsson, Olafur Indridason, Elin Ruth Reed, Gudlaug Katrin Hakonardottir, Hlif Steingrimsdottir, Malin Hultcrantz, Brian GM Durie, Stephen J. Harding, Thor Aspelund, Ola Landgren, Thorvardur Jon Love, Sigurdur Y. Kristinsson
Journal: Blood (2023)
<i>TP53</i> Variant Allele Frequency and Therapy-Related Setting Independently Predict Survival in Myelodysplastic Syndromes with Del(5q)
Authors: Farah Fleti, Onyee Chan, Najla H Al Ali, Aref Al-Kali, Kebede Begna, James M. Foran, Talha Badar, Nandita Khera, Mithun V Shah, Devendra Hiwase, Eric Padron, David A Sallman, Animesh D. Pardanani, Daniel A. Arber, Attilio Orazi, Kaaren K. Reichard, Rong He, Rhett Ketterling, Naseema Gangat, Rami S. Komrokji, Ayalew Tefferi
Journal: Blood (2023)
Mosunetuzumab Monotherapy Continues to Demonstrate Durable Responses in Patients with Relapsed and/or Refractory Follicular Lymphoma after ≥2 Prior Therapies: 3-Year Follow-up from a Pivotal Phase II Study
Authors: Stephen J. Schuster, Laurie H. Sehn, Nancy L. Bartlett, Matthew Matasar, Sarit Assouline, Pratyush Giri, John Kuruvilla, Mazyar Shadman, Chan Y. Cheah, Sascha Dietrich, Keith Fay, Matthew Ku, Loretta J. Nastoupil, Michael C. Wei, Shen Yin, Iris To, Jiangeng Huang, Antonia Kwan, Elicia Penuel, L. Elizabeth Budde
Journal: Blood (2023)
Clinical Characteristics, Treatment Trends, and Outcomes of Patients with HHV-8-Negative/Idiopathic Multicentric Castleman Disease Treated with Siltuximab in a Machine Learning-Selected Real-World Cohort
Authors: Aaron B Cohen, Melissa Estevez, Jonathan G Kelly, James N Gippetti, Erin L Fidyk, Joshua D. Brandstadter, David C. Fajgenbaum
Journal: Blood (2023)
Lymphodepletion Enables Successful BCMA CAR-T Cell Engraftment and Tumour Control in the Syngeneic Vk*MYC Model of Aggressive Myeloma
Authors: Lorenzo Lindo, Erin Meermeier, Lauren H Wilkinson, Silvia Selleri, Mehdi Arbabi Ghahroudi, Scott McComb, P. Leif Bergsagel, Marta Chesi, Laura Evgin, Daniel D Waller, Kevin A Hay
Journal: Blood (2023)
Preliminary Results of a Phase 2 Study of IMM01 Combined with Azacitidine (AZA) As the First-Line Treatment in Adult Patients with Higher Risk Myelodysplastic Syndromes (MDS)
Authors: Wei Yang, Sujun Gao, Xiaojing Yan, Rong Guo, Lijie Han, Fei Li, Yafei Wang, Junmin Li, Chunkang Chang, Haiping Yang, Ronghua Hu, Hongyan Tong, Xingli Zhao, Qiubai Li, Jingdong Zhang, Xin Du, Sanfang Tu, Cheng Zhang, Congmeng Lin, Xin Du, Zhenling Li, Ligen Liu, Zhenyu Li, Zheng Dong, Yixuan Yang, Qiying Lu, Wenzhi Tian, Zhijian Xiao
Journal: Blood (2023)
BCMA-Directed Low Dose Alpha-Emitter Therapy Eliminates Minimal Residual Disease in a Multiple Myeloma Mouse Xenograft Model
Authors: Melissa L Comstock, Shyril O'Steen, Yukang Lin, Donald Hamlin, D Scott Wilbur, Johnnie J. Orozco, Rainer F. Storb, Roland B. Walter, Pinar Ataca Atilla, Brian G Till, Geoffrey R Hill, Brenda M. Sandmaier, Damian J Green
Journal: Blood (2023)